-

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of Bed Bath & Beyond Inc.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Bed Bath & Beyond Inc. (“Bed Bath & Beyond” or the “Company”) (NASDAQ: BBBY) securities between October 2, 2019 and February 11, 2020, inclusive (the “Class Period”).

If you suffered a loss on your Bed Bath & Beyond investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information here or contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, via email shareholders@glancylaw.com or visit our website at www.glancylaw.com to learn more about your rights.

On January 8, 2020, Bed Bath & Beyond withdrew its fiscal 2019 guidance, purportedly due to pressures on sales and profitability, as well as a new strategic plan for the Company’s operations.

On this news, the Company’s share price fell $3.20, or over 19%, to close at $13.40 per share on January 9, 2020, on unusually heavy trading volume.

On February 11, 2020, Bed Bath & Beyond issued a press release announcing preliminary fourth quarter 2019 financial results. Therein, the Company disclosed "a 5.4% decline in comparable sales driven primarily by store traffic declines combined with inventory management issues," including that “inventory within certain key categories in the Bed Bath & Beyond assortment was too low or out-of-stock during the period.”

On this news, the Company's share price fell $3.06 per share, or over 20%, to close at $11.79 per share on February 12, 2020, on unusually heavy trading volume."

The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose: (1) that, due to “aggressive disposition of inventory,” the Company lacked sufficient inventory in key categories to support holiday sales; (2) that the Company’s internal control over inventory levels and financial reporting was not effective; (3) that, as a result of the foregoing, the Company was likely to experience reduced sales; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Bed Bath & Beyond securities during the Class Period, you may move the Court no later than June 15, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Glancy Prongay & Murray LLP

NASDAQ:BBBY

Release Summary
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of Bed Bath & Beyond Inc.
Release Versions
$Cashtags

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

More News From Glancy Prongay & Murray LLP

Glancy Prongay Wolke & Rotter LLP Ranked #2 in ISS SCAS “Top 50 Plaintiff Law Firms 2025” Report

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (formerly Glancy Prongay & Murray LLP) announced today that it has been ranked No. 2 nationally in Institutional Shareholder Services’ Securities Class Action Services (“ISS SCAS”) Top 50 Plaintiff Law Firms 2025 report, which ranks plaintiffs’ securities firms by the aggregate settlement amount achieved for shareholders in North American securities-related class action settlements during the 2025 calendar year. According t...

Securities Fraud Investigation Into NuScale Power Corporation (SMR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUSCALE POWER CORPORATION (SMR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Hap...

Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR INOVIO INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURS...
Back to Newsroom